Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 December 2018 | Story Leonie Bolleurs | Photo Sonia Small
David Abbey
David Abbey is also serving on the UFS Council’s Finance, Audit, Risk and IT Governance Committee.

David Abbey, a senior banker and transactor in the Acquisition and Leveraged Finance Division at Rand Merchant Bank in Johannesburg, was appointed to the UFS Council.

An undergraduate student of Rhodes University, David is also a proud product of the UFS, having completed his Accounting honours degree at this university. For the past few years, he has also guest lectured on investment banking and financial instruments to Accounting honours students as part of the PwC Financial Instruments Programme.

Large-scale impact

Therefore, his appointment to the Council is particularly special to him.

“Being a member of the Council gives me the platform to have a more large-scale impact on the institution, academic community, the economy, and society. I’m thrilled to be serving alongside an astute body of incredible individuals from whom I will undoubtedly learn,” he says.

Realising his full potential

David is serving on the Council’s Finance, Audit, Risk and IT Governance Committee and his experience in, and knowledge of finance, technology, and audit skills will stand him in good stead. When he’s not developing and structuring innovative, multidisciplinary, and integrated financial solutions for his corporate clients, he loves to be active. He is a regular gym-goer and plays and watches all kinds of sport. Travel, the arts, and motoring are some of his other passions. 

On a personal level, there is still much he wants to achieve. “I want to continue to work hard, using my God-given talents to realise my full potential and to make a humble mark in society and in people’s lives.”

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept